Literature DB >> 9605044

Predictive value of planar 18F-fluorodeoxyglucose imaging for cardiac events in patients after acute myocardial infarction.

J M Huitink1, F C Visser, J J Bax, A van Lingen, A B Groenveld, G J Teule, C A Visser.   

Abstract

This long-term study examines the predictive value of planar myocardial 18F-fluorodeoxyglucose (FDG) imaging for cardiac events after acute myocardial infarction (AMI). From December 1989 to April 1991, 59 consecutive patients with AMI had undergone planar rest thallium-201 (Tl-201)/FDG imaging for viability assessment; 53 (42 men) were included in this study. Mean follow-up was 47 +/- 15 months. Cardiac events were defined as cardiac-related death, reinfarction, late revascularization, and unstable angina pectoris. A mismatch pattern was defined as a FDG uptake exceeding Tl-201 uptake by > or = 20%. A concordant reduction in flow and metabolism was defined as a match. In the mismatch group (n = 39) were 19 events versus 1 event in the match group (n = 14) (p <0.009). In the mismatch group were 5 cardiac deaths, 3 reinfarctions, 7 late revascularizations, and 4 patients had unstable angina pectoris. There was 1 cardiac death in the match group. The event-free rate estimated using Kaplan Meier curves for patients with and without a mismatch was significantly different (p = 0.018). The relative risk for patients with a mismatch for developing a future cardiac event was estimated at 7.8 versus patients with a match. Thus, planar myocardial FDG imaging shortly after AMI has important prognostic significance for prediction of future cardiac events. Patients with a mismatch shortly after AMI have a high risk for future cardiac events on medical therapy.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9605044     DOI: 10.1016/s0002-9149(98)00143-x

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  9 in total

1.  F-18 fluorodeoxyglucose imaging in myocardial ischemia: beyond myocardial viability.

Authors:  J A Arrighi
Journal:  J Nucl Cardiol       Date:  2001 May-Jun       Impact factor: 5.952

2.  Viability assessment with MRI is superior to FDG-PET for viability: Pro.

Authors:  Jamshid Maddahi
Journal:  J Nucl Cardiol       Date:  2010-04       Impact factor: 5.952

Review 3.  Noninvasive assessment myocardial viability: current status and future directions.

Authors:  Kevin C Allman
Journal:  J Nucl Cardiol       Date:  2013-06-15       Impact factor: 5.952

4.  Incremental predictive value of myocardial scintigraphy with 123I-BMIPP in patients with acute myocardial infarction treated with primary percutaneous coronary intervention.

Authors:  Mamoru Nanasato; Haruo Hirayama; Akitada Ando; Satoshi Isobe; Makoto Nonokawa; Yoshimi Kinoshita; Ichiro Nanbu; Mitsuhiro Yokota; Toyoaki Murohara
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-07-01       Impact factor: 9.236

Review 5.  Contrast-enhanced magnetic resonance imaging in the assessment of myocardial infarction and viability.

Authors:  Antti Saraste; Stephan Nekolla; Markus Schwaiger
Journal:  J Nucl Cardiol       Date:  2007-12-21       Impact factor: 5.952

6.  B-type natriuretic peptide as a predictor of anterior wall location in patients with non-ST-elevation myocardial infarction.

Authors:  Rogério Bicudo Ramos; Célia M Strunz; Solange Desirée Avakian; José Antonio Ramires; Antonio de Padua Mansur
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

7.  Improved clinical outcome after invasive management of patients with recent myocardial infarction and proven myocardial viability: primary results of a randomized controlled trial (VIAMI-trial).

Authors:  Ramon B van Loon; Gerrit Veen; Leo H B Baur; Otto Kamp; Jean G F Bronzwaer; Jos W R Twisk; Freek W A Verheugt; Albert C van Rossum
Journal:  Trials       Date:  2012-01-03       Impact factor: 2.279

8.  Early and long-term outcome of elective stenting of the infarct-related artery in patients with viability in the infarct-area: Rationale and design of the Viability-guided Angioplasty after acute Myocardial Infarction-trial (The VIAMI-trial).

Authors:  Ramon B van Loon; Gerrit Veen; Otto Kamp; Jean Gf Bronzwaer; Cees A Visser; Frans C Visser
Journal:  Curr Control Trials Cardiovasc Med       Date:  2004-11-11

9.  Comparison of 18F SPECT with PET in myocardial imaging: a realistic thorax-cardiac phantom study.

Authors:  Karin Knešaurek; Josef Machac
Journal:  BMC Nucl Med       Date:  2006-10-31
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.